Search

Your search keyword '"D’Amato, D"' showing total 289 results

Search Constraints

Start Over You searched for: Author "D’Amato, D" Remove constraint Author: "D’Amato, D" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
289 results on '"D’Amato, D"'

Search Results

6. T.05.4: RENAL LITHOGENIC RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATES WITH MICROBIOTA COMPOSITION, URINARY PROFILE AND DIETARY INTAKE

9. P442 Renal lithogenic risk in patients with Inflammatory Bowel Diseases correlates with microbiota composition, urinary profile and dietary intake

10. Prognostic models and autoimmune liver diseases

14. Metric Learning in Histopathological Image Classification: Opening the Black Box

18. Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid

19. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

20. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

21. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

23. Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort

24. A nutrigenetic precision approach for the management of NAFLD

27. T.07.3 PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION

28. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

29. Social jetlag and mediterranean diet adherence are associated to liver fibrosis in patients with non-alcoholic fatty liver disease

30. Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study

31. Prognostic value of simple non-invasive tests for the risk stratification of hcc development in patients with cirrhosis due to non-alcoholic fatty liver disease

32. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

33. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

37. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

38. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

39. Real-world experience with obeticholic acid in patients with primary biliary cholangitis

40. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

41. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

42. Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies

44. New Therapeutic Targets in Autoimmune Cholangiopathies

45. Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis

46. On the prediction of keyholes by propagation of the MOID

47. Enforcing state constraints in dynamical systems modelled with neural networks

49. Technology for NASA's Planetary Science Vision 2050.

50. PC.01.8 RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS

Catalog

Books, media, physical & digital resources